Annals Of Pharmacotherapy

雜志介紹

Annals Of Pharmacotherapy雜志介紹

《Annals Of Pharmacotherapy》是一本以Multi-Language為主的未開放獲取國際優秀期刊，中文名稱藥物治療年鑒，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.3，最新CiteScore 指數為5.7。

本刊近期中國學者發表的論文主要有：

• Postoperative Application of Dexmedetomidine is the Optimal Strategy to Reduce the Incidence of Postoperative Delirium After Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials

  Author: Shang, Limei; Hou, Ming; Guo, Fengying

• The Efficacy and Safety of Sacubitril-Valsartan for the Treatment of Heart Failure in Adults: A Meta-Analysis

  Author: Tian, Qingshan; Xiong, Zhiping; Fan, HouDe; Ning, Ting; Zheng, ZhenZhong

• Effectiveness, Safety, and Predictors of Response to 5% Lidocaine-Medicated Plaster for the Treatment of Patients With Trigeminal Neuralgia: A Retrospective Study

  Author: Yu, Bin; Zhang, Wei; Zhao, Chunmei; Xing, Yan; Meng, Lan; Luo, Fang

• Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations

  Author: Wu, Tingting; Wu, Shuyi; Li, Meijuan; Zhang, Jinhua

英文介紹

Annals Of Pharmacotherapy雜志英文介紹

Annals of Pharmacotherapy?(AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. This journal is a member of the?Committee on Publication Ethics (COPE).?Average time from submission to first decision: 14 days